@owl v Fox has found the following highly relevant article which is very critical of ACW's science and very relevant to future progress or lack thereof.
https://seekingalpha.com/article/4269119-actinogen-disappoints-alzheimers-treatment-analysis-research-findings-identifies-major-issues
I'm starting a new thread because IMO the article deserves a thread to itself rather than being buried in an unrelated thread.
The author works for a small patent office called Strom Patent Law Firm in tbe USA. Looks like only two staff.
Her CV is here:
https://www.strompatentlawfirm.com/richelle-s-cv
In her CV, "WA" means Washington State USA, not Western Australia.
I'm not competent to comment on the article.
The article gets ACW's stock code wrong, but that's only a trivial detail.
@owl v Fox has found the following highly relevant article which...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.004(8.89%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.0¢ | $788.3K | 18.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 155092 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 198568 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |